01-Feb-18, Bloomberg
London-based digital health company Medopad Ltd. has signed over GBP100 mn (USD141 mn) in commercial projects and partnerships with Chinese firms.
Image: Bloomberg
Among the 15 different partnerships and projects the company announced were a collaboration with China’s Tencent Holdings to use artificial intelligence to support doctors’ decision-making, as well as deals with China Resources, Ping An Good Doctor, Lenovo New Vision, GSK China, UMP Healthcare, and Johnson & Johnson’s Vision Care division in Shanghai and its Actelion China pharmaceutical company.
Medopad sells a mobile app that lets doctors remotely monitor and connect with patients. The company is working with UBS Group AG to raise up to USD30 mn from private investors.